Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • VEGFR
    (167)
  • PDGFR
    (51)
  • Apoptosis
    (38)
  • c-Kit
    (35)
  • FGFR
    (34)
  • FLT
    (26)
  • Autophagy
    (19)
  • Src
    (17)
  • EGFR
    (14)
  • Others
    (70)
Filter
Search Result
Results for "

vegfr2

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    293
    TargetMol | Inhibitors_Agonists
  • Peptide Products
    5
    TargetMol | Peptide_Products
  • Inhibitory Antibodies
    4
    TargetMol | Inhibitory_Antibodies
  • Natural Products
    11
    TargetMol | Natural_Products
  • Recombinant Protein
    26
    TargetMol | Recombinant_Protein
  • Isotope Products
    8
    TargetMol | Isotope_Products
  • Antibody Products
    41
    TargetMol | Antibody_Products
  • Disease Modeling
    1
    TargetMol | Disease_Modeling_Products
VEGFR2-IN-1
T618992765224-55-1In house
VEGFR2-IN-1 is a selective and potent VEGFR2 inhibitor with antitumor activity that inhibits cell proliferation and migration and can be used in the study of breast cancer.
  • $293 TargetMol
In Stock
Size
QTY
Axitinib
AG-013736
T1452319460-85-0
Axitinib (AG-013736) is a multi-targeted tyrosine kinase inhibitor that inhibits VEGFR1, VEGFR2, VEGFR3, and PDGFRβ (IC50=4 20 0.4 2 nM). Axitinib has antitumor activity and is used in the treatment of renal cell carcinoma.
  • $33
In Stock
Size
QTY
TargetMol | Inhibitor Hot
Nintedanib
Intedanib, BIBF 1120
T1777656247-17-5
Nintedanib (Intedanib) is a triple vascular kinase inhibitor that inhibits VEGFR1, VEGFR2, and VEGFR3 (IC50=34 13 13 nM), FGFR1, FGFR2, and FGFR3 (IC50=69 37 108 nM), PDGFRα, and PDGFRβ (IC50=59 65 nM). Nintedanib has antitumor activity and inhibits tumor growth by inhibiting angiogenesis.
  • $38
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TG 100572 Hydrochloride
T13156L867331-64-4In house
TG 100572 Hydrochloride is a inhibitor of multi-targeted kinase which inhibits receptor tyrosine kinases and Src kinases(IC50s of 2, 7, 2, 16, 13, 5, 0.5, 6, 0.1, 0.4, 1, 0.2 nM for VEGFR1, VEGFR2, FGFR1, FGFR2, PDGFRβ, Fgr, Fyn, Hck, Lck, Lyn, Src, Yes, respectively).
  • $399
In Stock
Size
QTY
way-600
WAY600
T67301062159-35-6In house
WAY-600 is a potent, ATP-competitive, and selective inhibitor of mTOR with an IC50 of 9 nM; it blocks mTORC1 P-S6K(T389) and mTORC2 P-AKT(S473) but not P-AKT(T308), and is selective for mTOR over PI3Kα (>100-fold) and PI3Kγ (>500-fold).
  • $32
In Stock
Size
QTY
Pazopanib
GW786034
T0097L444731-52-6
Pazopanib (GW786034) is an inhibitor of protein tyrosine kinases that inhibits VEGFR1, VEGFR2, VEGFR3, PDGFRβ, c-Kit, FGFR1, and c-Fms (IC50=10 30 47 84 74 140 146 nM). Pazopanib has antitumor activity.
  • $42
In Stock
Size
QTY
Regorafenib
Fluoro-Sorafenib, BAY 73-4506
T1792755037-03-7
Regorafenib (BAY 73-4506) is an orally active, multi-targeted receptor tyrosine kinase inhibitor that inhibits RET, C-RAF, VEGFR2, c-Kit, VEGFR1, and PDGFRβ, exhibiting both antitumor and anti-angiogenic activity.
  • $30
In Stock
Size
QTY
Ponatinib
AP24534
T2372943319-70-8
Ponatinib (AP24534) is an orally available, multitargeted kinase inhibitor with IC50 values of 0.37 nM (Abl), 1.1 nM (PDGFRα), 1.5 nM (VEGFR2), 2.2 nM (FGFR1), and 5.4 nM (Src).
  • $35
In Stock
Size
QTY
Ponatinib Hydrochloride
Ponatinib hydrochloride, AP-24534 Hydrochloride, AP24534 Hydrochloride, AP 24534
T2372L1114544-31-8
Ponatinib Hydrochloride (AP-24534 Hydrochloride) is a hydrochloride of ponatinib. Ponatinib is an orally active multi-targeted kinase inhibitor with IC50s of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM, and 5.4 nM for Abl, PDGFRα, VEGFR2, FGFR1, and Src, respectively.
  • $39
In Stock
Size
QTY
GW786034B
Votrient HCl, Pazopanib HCl, GW786034 HCl
T6930635702-64-6
Pazopanib Hydrochloride (Votrient HCl) is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFR, FGFR, c-Kit and c-Fms with IC50 of 10 nM, 30 nM, 47 nM, 84 nM, 74 nM, 140 nM and 146 nM in cell-free assays, respectively.
  • $48
In Stock
Size
QTY
sitravatinib
MGCD516, MG516
T43491123837-84-2
Sitravatinib (MGCD516) is an inhibitor targeting multiple RTKs involved in driving sarcoma cell growth, including c-Met, c-Kit, PDGFRα β, PDGFR, and Axl.
  • $47
In Stock
Size
QTY
jnj-38158471
CS-2660
T22349951151-97-6
JNJ-38158471 (CS-2660), a highly selective, orally available, well tolerated VEGFR2 inhibitor with IC50 of 40 nM, inhibits closely related tyrosine kinases such as Ret and Kit with IC50 of 180 nM and 500 nM.
  • $34
In Stock
Size
QTY
TargetMol | Inhibitor Sale
bms-605541
BMS605541, BMS 605541
T26852639858-32-5
BMS-605541 is a potent and selective inhibitor of vascular endothelial growth factor receptor-2 (VEGFR-2) kinase activity(Ki=49 nM).
  • $31
In Stock
Size
QTY
TargetMol | Inhibitor Sale
jk-p3
T4425942655-44-9
JK-P3 is a pyrazole-based inhibitor of VEGFR-2 (IC50: 7.8 μM). JK-P3 inhibits FGFR 1 3 kinase activity in vitro, but has no effect on FGFR signaling in cell-based assays. The compound blocks wound healing and tube formation in HUVEC without effecting endo
  • $41
In Stock
Size
QTY
TargetMol | Inhibitor Sale
gw806742x
T11520579515-63-2
GW806742X is an inhibitor of Mixed Lineage Kinase Domain-Like protein (MLKL) which binds the MLKL pseudokinase domain (Kd: 9.3 μM) with anti-necroptosis activity. GW806742X has activity against VEGFR2.
  • $30
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Pamufetinib
TAS-115, H2OL3Q4XRD, 4-(2-Fluoro-4-(3-(2-phenylacetyl)thioureido)phenoxy)-7-methoxy-N-methylquinoline-6-carboxamide
T131081190836-34-0
Pamufetinib (TAS-115) is a potent kinase inhibitor targeting VEGFR and the hepatocyte growth factor receptor (c-Met HGFR), with IC50s of 30 nM for rVEGFR2 and 32 nM for rMET, respectively.
  • $46
In Stock
Size
QTY
Chiauranib
CS2164
T355701256349-48-0
Chiauranib is a multi-target inhibitor against tumor angiogenesis and exhibits potent anticancer effects. Chiauranib potently inhibits the angiogenesis-related kinases (VEGFR1, VEGFR2, VEGFR3, PDGFRα and c-Kit), mitosis-related kinase Aurora B, and chronic inflammation-related kinase CSF1R, with IC50 values ranging from 1-9 nM.
  • $67
In Stock
Size
QTY
EOC317
ACTB-1003, ACTB1003, ACTB 1003
T4318939805-30-8
EOC317 (ACTB-1003) is an oral kinase inhibitor with IC50 values of 6 nM, 2 nM, and 4 nM for FGFR1, VEGFR2, and Tie-2, respectively.
  • $93
In Stock
Size
QTY
Treprostinil Sodium
UT-15
T5171289480-64-4
Treprostinil Sodium (UT-15) is a potent DP1, IP and EP2 agonist (EC50: 0.6 1.9 6.2 nM).
  • $40
In Stock
Size
QTY
acrizanib
LHA510
T53731229453-99-9
Acrizanib (LHA510) is a VEGFR-2 inhibitor with an IC50 of 17.4 nM for BaF3-VEGFR-2.
  • $113
In Stock
Size
QTY
TargetMol | Inhibitor Sale
PF 477736
PF-477736, PF477736, PF 00477736
T6028952021-60-2
PF 477736 (PF-736,PF-00477736) is a specifc, effective and ATP-competitive Chk1 inhibitor (Ki: 0.49 nM ) and also inhibits FGFR3, Aurora-A, VEGFR2, Flt3, Fms (CSF1R), Ret and Yes.
  • $45
In Stock
Size
QTY
Dovitinib lactate hydrate
TKI258, Dovitinib Lactate, Dovitinib (TKI258) Lactate
T6479915769-50-5
Dovitinib lactate hydrate (TKI258) is the Lactate of Dovitinib, which is a multitargeted RTK inhibitor, mostly for class III (FLT3 c-Kit) with IC50 of 1 nM 2 nM, also potent to class IV (FGFR1 3) and class V (VEGFR1-4) RTKs with IC50 of 8-13 nM, less potent to InsR, EGFR, c-Met, EphA2, Tie2, IGFR1 and HER2. Phase 4.
  • $50
In Stock
Size
QTY
SU 5402
SU5402
T6996215543-92-3
SU 5402 is a potent multi-targeted receptor tyrosine kinase inhibitor with IC50 values of 20 nM for VEGFR2, 30 nM for FGFR1, and 510 nM for PDGF-Rβ.
  • $30
In Stock
Size
QTY
vegfr-2-in-29
T997962802-77-1
VEGFR-2-IN-29 is a VEGFR2 inhibitor.
  • $34
In Stock
Size
QTY